clinical trialCalmare Pain Therapy Treatment (scrambler therapy)
to treat chronic neuropathy
for people with
Multiple Sclerosis (MS) 

Sponsor:

Calmare Pain Therapy NJ / Rutherford Allied Medical Group

Principal Investigator:

Michael J. Cooney, D.C.
Calmare Therapy NJ / Rutherford Allied Medical Group

Location:

Rutherford, New Jersey (10 miles from New York City)

Study Start Date:

July 7, 2014

Details:

Calmare Therapy NJ / Rutherford Allied Medical Group, is one of only 10 certified providers of Calmare Pain Therapy Treatment®, an FDA-cleared, non-invasive, pain-free, drug-free technology to treat patients suffering from several types of long-term, high-intensity pain as a result of injury or disease.

Purpose:

Calmare Technology 2012We are conducting a clinical trial study for pre-qualified people with Multiple Sclerosis (MS) who have been suffering from the disease-related symptom of chronic neuropathy for more than one year. The purpose of the study is to determine if the MC5-A Calmare Therapy (scrambler therapy) machine can lessen or eliminate pain symptoms as a result of MS.

Candidate Criteria:

Pre-approved study participants must be available to undergo a protocol of 10 treatments, once per day lasting up to one hour. There is no charge for the series of 10 treatments but travel, meals and accommodations are at the expense of the approved trial participant.

To Apply / Contact Us / For More Information:

To find out more and determine if you may be an appropriate candidate for this no-cost study, please contact:

Dr. Michael Cooney
Clinical Director
Calmare Therapy NJ / Rutherford Allied Medical Group
(201) 933.4440 | calmarenj@gmail.com